Global Infusion Therapy Market is expected to grow at a CAGR of 7.2% during the forecast period 2020-2027
A new research report published by Fior Markets with the title Infusion Therapy Market By Type (Infusion Pump, Intravenous Set, Cannulas, Needleless Catheter), Application (Diabetes, HIV, Post-transplant Therapies, Hemophilia, Chemotherapy, Hydration Therapy, Pain Management, Total Parenteral Nutrition, Inotropic Therapy, Others), End-user (Home care, Ambulatory Surgical Centre, Hospitals, Special Clinics, others) Region, Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast 2020 To 2027.
The global Infusion Therapy market is expected to grow from USD 23.62 billion in 2019 to USD 41.20 billion by 2027, at a CAGR of 7.2% during the forecast period 2020-2027. North America has the highest growth in this market because of high rate of chronic or serious diseases like cardiovascular disease and diabetes. Europe being the second largest. The growth of infusion therapy market in Europe & North America is due to the increased investment by pharmaceutical companies and technological advancement. Asia Pacific region is the emerging market for infusion therapy because of rise in demand for low cost therapy.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418394/request-sample
The key players of this market are BioScrip, Inc., CareCentrix, Inc., Medical Services of America, Inc., Allina Health, ContinuumRx, Coram LLC, Cleveland Clinic, ICU Medical inc., OptionCare Enterprises.
These players are improving their market presence by collaborating and launching some new products. ICU medical acquired all the Pfizer’s infusion therapy and to deliver best in class, affordable and home- based care to patients, Shift labs introduced its DripAssist infusion rate.
The type segment includes, Infusion pump, intravenous set, cannulas, needleless catheter. Needless catheter will have the highest CARG in the coming years. As these offers safety. The application segment includes, Diabetes, HIV, post-transplant, therapies, haemophilia, chemotherapy, hydration therapy, pain management, total parenteral nutrition, inotropic therapy, others. Chemotherapy segment is projected to have fastest growth over the coming years due to the various initiatives taken to improve treatment facilities for cancer. The end use segment includes, home care, ambulatory surgical centres, hospitals, special clinics, others. Home care has the highest share in the end-user segment because of the individuals requiring long-term therapy. Home therapy is proven the most effective and safe alternative.
The key drives of this market are initiatives providers of health care services to support market growth and rising number of patients with serious disease like cancer or diabetes. The high cost of this therapy in cardiovascular and chemotherapeutic drug can hinder the growth of this market.
About the report:
The global Infusion Therapy market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on email@example.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire